The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette–Guérin immunotherapy: Current status

OBJECTIVE: To summarise the current evidence of the significance and prognostic value of programmed cell death protein ligand 1 (PD-L1) expression in patients with non-muscle-invasive bladder cancer (NMIBC) treated with bacille Calmette–Guérin (BCG) immunotherapy. METHODS: A search was conducted in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowak, Łukasz, Krajewski, Wojciech, Poterek, Adrian, Śliwa, Anna, Zdrojowy, Romuald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Management of NMIBC
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954482/
https://www.ncbi.nlm.nih.gov/pubmed/33763250
http://dx.doi.org/10.1080/2090598X.2020.1791562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954482/
https://www.ncbi.nlm.nih.gov/pubmed/33763250
http://dx.doi.org/10.1080/2090598X.2020.1791562

Ejemplares similares